These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1227 related articles for article (PubMed ID: 19010828)
21. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study. Singh R; Ray P; Das A; Sharma M Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203 [TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308 [TBL] [Abstract][Full Text] [Related]
23. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350 [TBL] [Abstract][Full Text] [Related]
24. Low-energy shock waves enhance the susceptibility of staphylococcal biofilms to antimicrobial agents in vitro. Wanner S; Gstöttner M; Meirer R; Hausdorfer J; Fille M; Stöckl B J Bone Joint Surg Br; 2011 Jun; 93(6):824-7. PubMed ID: 21586784 [TBL] [Abstract][Full Text] [Related]
25. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms. Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms. Bakkiyaraj D; Pandian SK Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890 [TBL] [Abstract][Full Text] [Related]
27. Pyrrolomycins as potential anti-staphylococcal biofilms agents. Schillaci D; Petruso S; Raimondi MV; Cusimano MG; Cascioferro S; Scalisi M; La Giglia MA; Vitale M Biofouling; 2010; 26(4):433-8. PubMed ID: 20234952 [TBL] [Abstract][Full Text] [Related]
28. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. Cargill JS; Upton M J Clin Pathol; 2009 Dec; 62(12):1112-6. PubMed ID: 19640858 [TBL] [Abstract][Full Text] [Related]
29. Effect of berberine on Staphylococcus epidermidis biofilm formation. Wang X; Yao X; Zhu Z; Tang T; Dai K; Sadovskaya I; Flahaut S; Jabbouri S Int J Antimicrob Agents; 2009 Jul; 34(1):60-6. PubMed ID: 19157797 [TBL] [Abstract][Full Text] [Related]
30. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters. García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868 [TBL] [Abstract][Full Text] [Related]
31. Potency and penetration of telavancin in staphylococcal biofilms. Kirker KR; Fisher ST; James GA Int J Antimicrob Agents; 2015 Oct; 46(4):451-5. PubMed ID: 26213381 [TBL] [Abstract][Full Text] [Related]
32. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Hajdu S; Lassnigg A; Graninger W; Hirschl AM; Presterl E J Orthop Res; 2009 Oct; 27(10):1361-5. PubMed ID: 19396814 [TBL] [Abstract][Full Text] [Related]
33. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms. Melchior MB; Fink-Gremmels J; Gaastra W Vet Microbiol; 2007 Nov; 125(1-2):141-9. PubMed ID: 17600640 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays. Abbanat D; Shang W; Amsler K; Santoro C; Baum E; Crespo-Carbone S; Lynch AS Int J Antimicrob Agents; 2014 Jan; 43(1):32-9. PubMed ID: 24252780 [TBL] [Abstract][Full Text] [Related]
35. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections. Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044 [TBL] [Abstract][Full Text] [Related]
38. Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities. Kadry AA; Fouda SI; Shibl AM; Abu El-Asrar AA J Antimicrob Chemother; 2009 Mar; 63(3):480-4. PubMed ID: 19147522 [TBL] [Abstract][Full Text] [Related]
39. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. Lee CK; Rubin LG; Moldwin RM Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861 [TBL] [Abstract][Full Text] [Related]
40. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]